Clinical and Neurocognitive Assessment of Adolescents and Young Adults at Risk for Serious Psychiatric Disorders

Description

The Prodrome Assessment Research and Treatment (PART) Program is conducting this study to learn about risk factors for the future development of serious psychiatric illnesses such as schizophrenia.

Study Design

The procedures consist of interviews and questionnaires, computer and paper and pencil tests, and blood tests, conducted at no cost. Evaluations may be repeated on several occasions over a period of up to 2 years.

End Date

4/30/2013

Principal Investigators

Sophia Vinogradov, MD

Participant Requirements

We are looking for individuals ages 12-35 who are experiencing recent changes in their thoughts, feelings, and behavior, such as unusual thoughts, distorted or changed perception of sights or sounds, ideas of special identity or abilities, suspiciousness, or odd behavior. Other changes may include reduced concentration, reduced energy, depressed mood, sleep disturbance, withdrawal from family or friends, trouble with work or school, anxiety, or irritability. Individuals who are experiencing difficulty functioning and who have a parent or sibling with a psychotic illness, such as schizophrenia, are also encouraged to contact us.

Payment

There is no payment for participation. Treatment is an optional component of this study.  Treatment is not required.

Contact Info

Rachel Loewy, PhD - Contact Information
415-476-7278

Research Programs

Prodrome Assessment Research and Treatment Program (PART)

 

Leadership in research, education, psychiatric care and public service